Abstract
Intellectual property rights (IPRs) occupy the center-stage when path-breaking technologies are adopted in product manufacture for the benefit of the society. Timely protection of IP plays a crucial role in enjoying the exclusivity over the products by the brand name companies, of course, paving a way towards the entry of the generic players during the life cycle of the product(s). Several domestic and international policies, rules and regulations guide/affect at every stage of the life cycle of the product. Intellectual property rights (IPRs) are the integral part of the executive bodies of the companies in general and in specific to the bio-process technology. A product’s success in the markets can be attributed to its beneficial distinctive features over the existing products/knowledge. Non-existent prior art pertaining to the product/knowledge gives the defined distinctiveness and enable the manufacturer to enjoy the exclusivities for a definite period of time. Innovations relating to the bio-processing sector normally see the churning out of ideas, reduction to practice and ultimately taking them to the market place.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
http://www.wipo.int/edocs/pubdocs/en/global_challenges/628/wipo_pub_628.pdf. Retrieved October 9, 2014.
http://www.wipo.int/edocs/pubdocs/en/copyright/955/wipo_pub_955.pdf. Retrieved October 10, 2014.
Pugatch, M. P., et al. (2012). How global biotechnology benefits from intellectual property rights. New York, NY: Pugatch Consilium.
http://www.wipo.int/export/sites/www/ipstats/en/wipi/2013/pdf/wipo_pub_941_2013_section_a.pdf. Retrieved October 13, 2014.
AUTM Licensing Survey, FY 2002 survey summary. Retrieved October 15, 2014, from http://www.autm.net/surveys/02/2002spublic.pdf.
http://www.autm.net/AM/Template.cfm?Section=FY_2013_Licensing_Activity_Survey&Template=/CM/ContentDisplay.cfm&ContentID=13870. Retrieved October 15, 2014.
University of California. (2011). Technology transfer annual report 2011, p. 25.
http://www.whitehouse.gov/ostp/pcast. Retrieved October 15, 2014.
Kesselheim, A. S., & Avorn, J. (2005). University-based science and biotechnology products: Defining the boundaries of intellectual property. JAMA, 293, 850–854.
http://www.wto.org/english/thewto_e/whatis_e/tif_e/fact1_e.htm. Retrieved October 16, 2014.
http://www.wto.org/english/tratop_e/trips_e/tripsfactsheet_pharma_2006_e.pdf. Retrieved October 16, 2014.
http://www.wipo.int/export/sites/www/freepublications/en/statistics/943/wipo_pub_943_2013.pdf. Retrieved October 16, 2014.
http://www.wipo.int/edocs/pubdocs/en/copyright/450/wipo_pub_l450cr.pdf. Retrieved October 16, 2014.
http://www.wipo.int/edocs/pubdocs/en/intproperty/909/wipo_pub_909.pdf. Retrieved October 16, 2014.
http://www.wipo.int/edocs/pubdocs/en/copyright/844/wipo_pub_844.pdf. Retrieved October 17, 2014.
http://www.wipo.int/export/sites/www/freepublications/en/statistics/943/wipo_pub_943_2013.pdf. Retrieved October 17, 2014.
http://www.wipo.int/edocs/pubdocs/en/marks/418/wipo_pub_418.pdf. Retrieved October 17, 2014.
http://www.wipo.int/edocs/pubdocs/en/marks/1039/wipo_pub_1039.pdf. Retrieved October 17, 2014.
http://www.trademarkcases.ca/ciba-geigy-canada-ltd-v-apotex-inc-1992-3-s-c-r-120/. Retrieved October 17, 2014.
http://en.wikipedia.org/wiki/Ciba-Geigy_Canada_Ltd._v._Apotex_Inc. Retrieved October 17, 2014.
http://www.wipo.int/edocs/pubdocs/en/geographical/952/wipo_pub_952.pdf . Retrieved October 17, 2014.
Mukherjee, U. (2008). A study of the basmati case (India-US basmati rice dispute): The geographical indication perspective. SSRN. http://ssrn.com/abstract=1143209.
http://www.wipo.int/designs/en/. Retrieved October 17, 2014.
http://decisions.fct-cf.gc.ca/fc-cf/decisions/en/item/61469/index.do. Retrieved October 17, 2014.
http://www.wto.org/english/tratop_e/trips_e/tripsfactsheet_pharma_2006_e.pdf. Retrieved October 17, 2014.
http://www.wipo.int/export/sites/www/pct/en/seminar/basic_1/timeline.pdf. Retrieved October 17, 2014.
http://www.uspto.gov/web/offices/pac/mpep/s2104.html. Retrieved October 17, 2014.
http://www.uspto.gov/patents/resources/general_info_concerning_patents.jsp#heading-27. Retrieved October 17, 2014.
http://documents.lexology.com/2284cfd8-021d-40a8-be6e-875943f0507e.pdf. Retrieved October 17, 2014.
http://www.lexology.com/library/detail.aspx?g=3f92413f-107c-4886-aca7-24633a341e22. Retrieved October 17, 2014.
http://www.novartisoncology.com/. Retrieved October 17, 2014.
http://www.wto.org/english/tratop_e/trips_e/intel2_e.htm#layoutdesigns . Retrieved October 20, 2014.
http://www.wto.org/english/docs_e/legal_e/27-trips.pdf. Retrieved October 10, 2014.
http://www.wipo.int/sme/en/ip_business/trade_secrets/trade_secrets.htm. Retrieved October 10, 2014.
http://www.wipo.int/export/sites/www/sme/en/documents/wipo_magazine/04_2002.pdf. Retrieved October 10, 2014.
Trade Secret Case Law – 2013; Retrieved October 16, 2014, from www.apps.americanbar.org.
http://www.wipo.int/about-wipo/en/. Retrieved October 9, 2014.
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm289601.htm. Retrieved May 22, 2014.
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/default.htm. Retrieved April 7, 2014.
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm. Retrieved April 14, 2014.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070124.pdf. Retrieved April 18, 2014.
http://thomas.loc.gov/cgi-bin/bdquery/z?d098:SN01538:@@@D&summ2=m&|TOM:/bss/d098query.html. Retrieved September 12, 2014.
http://www.camargopharma.com/Userfiles/whitepaper/Cmrgo_WhitePaperApprovalPthwy_VFb.pdf. Retrieved July 2, 2014.
21 CFR 314.54 – 505(b)(2) applications. Retrieved October 13, 2014.
www.regprofessional.com. Retrieved October 13, 2014.
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm241718.htm. Retrieved October 13, 2014.
Saenger, P. (2012). Current status of biosimilar growth hormone. The Indian Journal of Pediatrics, 79(1), 92–98.
http://www.genengnews.com/gen-news-highlights/sandoz-launches-somatropin-biosimilar-in-japan/64624116/. Retrieved October 13, 2014.
http://www.celltrion.com/en/COMPANY/notice_view.asp?idx=456&code=ennews&intNowPage=1&menu_num=&align_year=all. Retrieved October 13, 2014.
Cohen, J. C., & Illingworth, P. (2003). The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements. Developing World Bioethics, 3(1), 27–48.
Baker, B. K. (2009). Patents, pricing, and access to essential medicines in developing countries, virtual mentor. American Medical Association Journal of Ethics, 11(7), 527–532.
http://www.medicinespatentpool.org/about/. Retrieved October 13, 2014.
http://www.wipo.int/export/sites/www/ip-competition/en/studies/patent_pools_report.pdf. Retrieved 13 Oct 2014.
http://en.wikipedia.org/wiki/M%C3%A9decins_Sans_Fronti%C3%A8res. Retrieved October 13, 2014.
http://www.wto.org/english/news_e/pres03_e/pr350_e.htm. Retrieved October 9, 2014.
http://www.lexology.com/library/detail.aspx?g=5dc7c10a-7a1b-4b09-a387-7aa7a09b5c95. Retrieved October 17, 2014.
http://www.ip-watch.org/2013/03/04/indias-first-compulsory-licence-upheld-but-legal-fights-likely-to-continue/. Retrieved October 20, 2014.
http://en.wikipedia.org/wiki/Roche_Products_v._Bolar_Pharmaceutical. Retrieved October 16, 2014.
Acknowledgements
The author is thankful to DBT-India towards DBT-CREST Fellowship and to CSIR-CDRI, India for all support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kulkarni, S.R. (2015). Intellectual Property Rights-Protection and Regulation. In: Ravindra, P. (eds) Advances in Bioprocess Technology. Springer, Cham. https://doi.org/10.1007/978-3-319-17915-5_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-17915-5_23
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17914-8
Online ISBN: 978-3-319-17915-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)